Protein kinase signaling at the crossroads of myocyte life and death in ischemic heart disease

Drug Discovery Today: Therapeutic Strategies

Volumn 9, Issue 4, 2012, Pages

  Vagnozzi, Ronald J ^a   Hoffman, Nicholas E ^b   Elrod, John W ^b   Madesh, Muniswamy ^b   Force, Thomas ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; GLYCOGEN SYNTHASE KINASE 3; HEXOKINASE; MEMBRANE PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P53; RECEPTOR INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM TRANSPORT; CELL DEATH; HEART MUSCLE CELL; HUMAN; INHIBITION KINETICS; ISCHEMIC HEART DISEASE; MITOCHONDRIAL PERMEABILITY; NECROPTOSIS; NONHUMAN; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84900810782     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2013.12.001     Document Type: Review

References (94)

1. F. Di Lisa, and P. Bernardi A CaPful of mechanisms regulating the mitochondrial permeability transition J Mol Cell Cardiol 46 2009 775 780
2. C.P. Baines, R.A. Kaiser, T. Sheiko, W.J. Craigen, and J.D. Molkentin Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death Nat Cell Biol 9 2007 550 555
3. C.P. Baines, R.A. Kaiser, N.H. Purcell, N.S. Blair, H. Osinska, and M.A. Hambleton et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 2005 658 662
4. T. Nakagawa, S. Shimizu, T. Watanabe, O. Yamaguchi, K. Otsu, and H. Yamagata et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death Nature 434 2005 652 658
5. C.P. Baines How and when do myocytes die during ischemia and reperfusion: the late phase J Cardiovasc Pharmacol Ther 16 3-4 2011 239 243
6. F. Ichas, and J.P. Mazat From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state Biochim Biophys Acta 1366 1-2 1998 33 50
7. J.W. Elrod, R. Wong, S. Mishra, R.J. Vagnozzi, B. Sakthievel, and S.A. Goonasekera et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice J Clin Invest 120 10 2010 3680 3687
8. P. Korge, L. Yang, J.H. Yang, Y. Wang, Z. Qu, and J.N. Weiss Protective role of transient pore openings in calcium handling by cardiac mitochondria J Biol Chem 286 40 2011 34851 34857
9. J.W. Elrod, and J.D. Molkentin Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore Circ J 77 5 2013 1111 1122
10. F. Di Lisa, M. Canton, A. Carpi, N. Kaludercic, R. Menabò, and S. Menazza et al. Mitochondrial injury and protection in ischemic pre- and postconditioning Antioxid Redox Signal 14 5 2011 881 891
11. F. Di Lisa, and P. Bernardi Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole Cardiovasc Res 70 2 2006 191 199
12. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 11 2007 1121 1135
13. A.P. Halestrap Mitochondrial calcium in health and disease Biochim Biophys Acta 1787 11 2009 1289 1290
14. D.J. Hausenloy, M.R. Duchen, and D.M. Yellon Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury Cardiovasc Res 60 3 2003 617 625
15. L. Argaud, L. Gomez, O. Gateau-Roesch, E. Couture-Lepetit, J. Loufouat, and D. Robert et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury J Mol Cell Cardiol 39 6 2005 893 899
16. M.A. Sussman, M. Völkers, K. Fischer, B. Bailey, C.T. Cottage, and S. Din et al. Myocardial AKT: the omnipresent nexus Physiol Rev 91 3 2011 1023 1070
17. D.A. Linseman, B.D. Butts, T.A. Precht, R.A. Phelps, S.S. Le, and T.A. Laessig et al. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis J Neurosci 24 44 2004 9993 10002
18. M. Juhaszova, D.B. Zorov, S.H. Kim, S. Pepe, Q. Fu, and K.W. Fishbein et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 11 2004 1535 1549
19. M. Nishihara, T. Miura, T. Miki, J. Sakamoto, M. Tanno, and H. Kobayashi et al. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta Am J Physiol Heart Circ Physiol 291 2 2006 H748 H755
20. T. Miki, T. Miura, H. Hotta, M. Tanno, T. Yano, and T. Sato et al. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition Diabetes 58 12 2009 2863 2872
21. L. Gomez, M. Paillard, H. Thibault, G. Derumeaux, and M. Ovize et al. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion Circulation 117 21 2008 2761 2768
22. A. Rasola, M. Sciacovelli, F. Chiara, B. Pantic, W.S. Brusilow, and P. Bernardi Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition Proc Natl Acad Sci U S A 107 2 2010 726 731
23. E. Murphy, and C. Steenbergen Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury Physiol Rev 88 2 2008 581 609
24. R.S. Whelan, K. Konstantinidis, A.C. Wei, Y. Chen, D.E. Reyna, and S. Jha et al. Bax regulates primary necrosis through mitochondrial dynamics Proc Natl Acad Sci U S A 109 17 2012 6566 6571
25. J. Karch, J.Q. Kwong, A.R. Burr, M.A. Sargent, J.W. Elrod, and P.M. Peixoto et al. Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice Elife 2 2013 e00772
26. H. Lal, J. Zhou, F. Ahmad, R. Zaka, R.J. Vagnozzi, and M. Decaul et al. Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death Circulation 125 1 2012 65 75
27. G. Beutner, A. Ruck, B. Riede, W. Welte, and D. Brdiczka Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore FEBS Lett 396 2-3 1996 189 195
28. G. Beutner, A. Rück, B. Riede, and D. Brdiczka Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases Biochim Biophys Acta 1368 1 1998 7 18
29. J. Camacho-Pereira, L.E. Meyer, L.B. Machado, M.F. Oliveira, and A. Galina Reactive oxygen species production by potato tuber mitochondria is modulated by mitochondrially bound hexokinase activity Plant Physiol 149 2 2009 1099 1110
30. W.S. da-Silva, A. Gómez-Puyou, M.T. de Gómez-Puyou, R. Moreno-Sanchez, F.G. De Felice, and L. de Meis et al. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria J Biol Chem 279 38 2004 39846 39855
31. F. Chiara, D. Castellaro, O. Marin, V. Petronilli, W.S. Brusilow, and M. Juhaszova et al. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels PLoS ONE 3 3 2008 e1852
32. A.V. Vaseva, N.D. Marchenko, K. Ji, S.E. Tsirka, S. Holzmann, and U.M. Moll p53 opens the mitochondrial permeability transition pore to trigger necrosis Cell 149 7 2012 1536 1548
33. X. Long, M.O. Boluyt, M.L. Hipolito, M.S. Lundberg, J.S. Zheng, and L. O'Neill et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes J Clin Invest 99 11 1997 2635 2643
34. A. Toth, P. Nickson, L.L. Qin, and P. Erhardt Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase J Biol Chem 281 6 2006 3679 3689
35. A. Parcellier, L.A. Tintignac, E. Zhuravleva, and B.A. Hemmings PKB and the mitochondria: AKTing on apoptosis Cell Signal 20 1 2008 21 30
36. M.S. Willis, and C. Patterson Into the heart: the emerging role of the ubiquitin-proteasome system J Mol Cell Cardiol 41 4 2006 567 579
37. J. Karch, and J.D. Molkentin Is p53 the long-sought molecular trigger for cyclophilin D-regulated mitochondrial permeability transition pore formation and necrosis? Circ Res 111 10 2012 1258 1260
38. S. Wolff, S. Erster, G. Palacios, and U.M. Moll p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity Cell Res 18 7 2008 733 744
39. G. Kung, K. Konstantinidis, and R.N. Kitsis Programmed necrosis, not apoptosis, in the heart Circ Res 108 8 2011 1017 1036
40. R.S. Whelan, V. Kaplinskiy, and R.N. Kitsis Cell death in the pathogenesis of heart disease: mechanisms and significance Annu Rev Physiol 72 2010 19 44
41. M. Chiong, Z.V. Wang, Z. Pedrozo, D.J. Cao, R. Troncoso, and M. Ibacache et al. Cardiomyocyte death: mechanisms and translational implications Cell Death Dis 2 2011 e244
42. W. Declercq, T. Vanden Berghe, and P. Vandenabeele RIP kinases at the crossroads of cell death and survival Cell 138 2 2009 229 232
43. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer Molecular mechanisms of necroptosis: an ordered cellular explosion Nat Rev Mol Cell Biol 11 10 2010 700 714
44. B.Z. Stanger, P. Leder, T.H. Lee, E. Kim, and B. Seed RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death Cell 81 4 1995 513 523
45. X. Sun, J. Yin, M.A. Starovasnik, W.J. Fairbrother, and V.M. Dixit Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3 J Biol Chem 277 11 2002 9505 9511
46. N. Holler, R. Zaru, O. Micheau, M. Thome, A. Attinger, and S. Valitutti et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule Nat Immunol 1 6 2000 489 495
47. N. Harper, M. Hughes, M. MacFarlane, and G.M. Cohen Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis J Biol Chem 278 28 2003 25534 25541
48. F.K. Chan, J. Shisler, J.G. Bixby, M. Felices, L. Zheng, and M. Appel et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses J Biol Chem 278 51 2003 51613 51621
49. A. Degterev, J. Hitomi, M. Germscheid, I.L. Ch'en, O. Korkina, and X. Teng et al. Identification of RIP1 kinase as a specific cellular target of necrostatins Nat Chem Biol 4 5 2008 313 321
50. Y.S. Kim, J. Hitomi, M. Germscheid, I.L. Ch'en, O. Korkina, and X. Teng et al. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death Mol Cell 26 5 2007 675 687
51. H.M. Shen, Y. Lin, S. Choksi, J. Tran, T. Jin, and L. Chang et al. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death Mol Cell Biol 24 13 2004 5914 5922
52. Y. Ma, V. Temkin, H. Liu, and R.M. Pope NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein J Biol Chem 280 51 2005 41827 41834
53. Y. Xu, S. Huang, Z.G. Liu, and J. Han Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation J Biol Chem 281 13 2006 8788 8795
54. S. He, L. Wang, L. Miao, T. Wang, F. Du, and L. Zhao et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha Cell 137 6 2009 1100 1111
55. M.J. Bertrand, S. Milutinovic, K.M. Dickson, W.C. Ho, A. Boudreault, and J. Durkin et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination Mol Cell 30 6 2008 689 700
56. L. Wang, F. Du, and X. Wang TNF-alpha induces two distinct caspase-8 activation pathways Cell 133 4 2008 693 703
57. Y.S. Cho, S. Challa, D. Moquin, R. Genga, T.D. Ray, and M. Guildford et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation Cell 137 6 2009 1112 1123
58. L. Galluzzi, T. Vanden Berghe, N. Vanlangenakker, S. Buettner, T. Eisenberg, and P. Vandenabeele et al. Programmed necrosis from molecules to health and disease Int Rev Cell Mol Biol 289 2011 1 35
59. Z. Wang, H. Jiang, S. Chen, F. Du, and X. Wang The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways Cell 148 1-2 2012 228 243
60. L. Chen, and A.A. Knowlton Mitochondrial dynamics in heart failure Congest Heart Fail 17 6 2011 257 261
61. R.S. Carreira, P. Lee, and R.A. Gottlieb Mitochondrial therapeutics for cardioprotection Curr Pharm Des 17 20 2011 2017 2035
62. S.S. Palaniyandi, X. Qi, G. Yogalingam, J.C. Ferreira, and D. Mochly-Rosen Regulation of mitochondrial processes: a target for heart failure Drug Discov Today Dis Mech 7 2 2010 e95 e102
63. K.M. Irrinki, K. Mallilankaraman, R.J. Thapa, H.C. Chandramoorthy, F.J. Smith, and N.R. Jog et al. Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis Mol Cell Biol 31 18 2011 3745 3758
64. A. Degterev, Z. Huang, M. Boyce, Y. Li, P. Jagtap, and N. Mizushima et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury Nat Chem Biol 1 2 2005 112 119
65. C.C. Smith, S.M. Davidson, S.Y. Lim, J.C. Simpkin, J.S. Hothersall, and D.M. Yellon Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21 4 2007 227 233
66. S.Y. Lim, S.M. Davidson, M.M. Mocanu, D.M. Yellon, and C.C. Smith The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore Cardiovasc Drugs Ther 21 6 2007 467 469
67. M.I. Oerlemans, J. Liu, F. Arslan, K. den Ouden, B.J. van Middelaar, and P.A. Doevendans et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo Basic Res Cardiol 107 4 2012 270
68. F. Perocchi, V.M. Gohil, H.S. Girgis, X.R. Bao, J.E. McCombs, and A.E. Palmer et al. MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake Nature 467 7313 2010 291 296
69. K. Mallilankaraman, P. Doonan, C. Cárdenas, H.C. Chandramoorthy, M. Müller, and R. Miller et al. MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival Cell 151 3 2012 630 644
70. K. Mallilankaraman, C. Cárdenas, P.J. Doonan, H.C. Chandramoorthy, K.M. Irrinki, and T. Golenár et al. MCUR1 is an essential component of mitochondrial Ca(2+) uptake that regulates cellular metabolism Nat Cell Biol 14 12 2012 1336 1343
71. 2+ in a cardiac myocyte J Mol Cell Cardiol 52 2 2012 317 322
72. B. O'Rourke Pathophysiological and protective roles of mitochondrial ion channels J Physiol 529 Pt 1 2000 23 36
73. S. Orrenius, B. Zhivotovsky, and P. Nicotera Regulation of cell death: the calcium-apoptosis link Nat Rev Mol Cell Biol 4 7 2003 552 565
74. M. Vila-Petroff, M.A. Salas, M. Said, C.A. Valverde, L. Sapia, and E. Portiansky et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury Cardiovasc Res 73 4 2007 689 698
75. 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice J Clin Invest 119 5 2009 1230 1240
76. 2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium Circ Res 107 9 2010 1150 1161
77. M.E. Anderson, J.H. Brown, and D.M. Bers CaMKII in myocardial hypertrophy and heart failure J Mol Cell Cardiol 51 4 2011 468 473
78. T. Bányász, N. Szentandrássy, A. Tóth, P.P. Nánási, J. Magyar, and Y. Chen-Izu Cardiac calmodulin kinase: a potential target for drug design Curr Med Chem 18 24 2011 3707 3713
79. S. Currie, E.B. Elliott, G.L. Smith, and C.M. Loughrey Two candidates at the heart of dysfunction: the ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention - an in vivo perspective Pharmacol Ther 131 2 2011 204 220
80. Y. Yang, W.Z. Zhu, M.L. Joiner, R. Zhang, C.V. Oddis, and Y. Hou et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo Am J Physiol Heart Circ Physiol 291 6 2006 H3065 H3075
81. 2+-calmodulin protein kinase II and promotes a death pathway conserved across different species Circ Res 105 12 2009 1204 1212
82. W. Zhu, A.Y. Woo, D. Yang, H. Cheng, M.T. Crow, and R.P. Xiao Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis J Biol Chem 282 14 2007 10833 10839
83. 2+/calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB Circ Res 112 6 2013 935 944
84. M. Joiner, O.M. Koval, J. Li, B.J. He, C. Allamargot, and Z. Gao et al. CaMKII determines mitochondrial stress responses in heart Nature 491 7423 2012 269 273
85. R.N. Correll, and J.D. Molkentin CaMKII does it again: even the mitochondria cannot escape its influence Circ Res 112 9 2013 1208 1211
86. J.R. Erickson, M.L. Joiner, X. Guan, W. Kutschke, J. Yang, and C.V. Oddis et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation Cell 133 3 2008 462 474
87. M. Luo, X. Guan, E.D. Luczak, D. Lang, W. Kutschke, and Z. Gao et al. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII J Clin Invest 123 3 2013 1262 1274
88. N.D. Roe, and J. Ren Oxidative activation of Ca(2+)/calmodulin-activated kinase II mediates ER stress-induced cardiac dysfunction and apoptosis Am J Physiol Heart Circ Physiol 304 6 2013 H828 H839
89. M. Plovanich, R.L. Bogorad, Y. Sancak, K.J. Kamer, L. Strittmatter, and A.A. Li et al. MICU2, a paralog of MICU1, resides within the mitochondrial uniporter complex to regulate calcium handling PLoS ONE 8 2 2013 e55785
90. S. Mishra, C.B. Gray, S. Miyamoto, D.M. Bers, and J.H. Brown Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes Circ Res 109 12 2011 1354 1362
91. L.D. McCullough, S. Tarabishy, L. Liu, S. Benashski, Y. Xu, and T. Ribar et al. Inhibition of calcium/calmodulin-dependent protein kinase kinase β and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia Stroke 44 9 2013 2559 2566
92. T. Force, K. Kuida, M. Namchuk, K. Parang, and J.M. Kyriakis Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease Circulation 109 10 2004 1196 1205
93. S.R. Houser, K.B. Margulies, A.M. Murphy, F.G. Spinale, G.S. Francis, and S.D. Prabhu et al. Animal models of heart failure: a scientific statement from the American Heart Association Circ Res 111 1 2012 131 150
94. S.W. Tait, A. Oberst, G. Quarato, S. Milasta, M. Haller, and R. Wang et al. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis Cell Rep 5 4 2013 878 885